Cartesian Therapeutics, Inc.
RNAC· Nasdaq
Cartesian Therapeutics, Inc.
- Last sale
- Oct 2, 2026 · +2.35%
- Market cap
- $223.89M
- 30.26M shares
- Filings
- 874
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $2,797,000 | reported | |
| FY 2024 | 2024-12-31 | $38,913,000 | reported | |
| FY 2023 | 2023-12-31 | $26,004,000 | reported | |
| FY 2022 | 2022-12-31 | $110,777,000 | reported | |
| FY 2021 | 2021-12-31 | $85,077,000 | reported | |
| FY 2020 | 2020-12-31 | $16,597,000 | reported | |
| FY 2019 | 2019-12-31 | $6,677,000 | reported | |
| FY 2018 | 2018-12-31 | $903,000 | reported | |
| FY 2017 | 2017-12-31 | $207,000 | reported | |
| FY 2016 | 2016-12-31 | $8,083,000 | reported | |
| FY 2015 | 2015-12-31 | $6,011,000 | reported | |
| FY 2014 | 2014-12-31 | $3,040,000 | reported |
Cartesian Therapeutics, Inc. · CIK 1453687 · Engraved from SEC EDGAR
